tradingkey.logo

Tempus AI Inc

TEM
54.910USD
+2.470+4.71%
收盤 02/06, 16:00美東報價延遲15分鐘
9.76B總市值
虧損本益比TTM

Tempus AI Inc

54.910
+2.470+4.71%

關於 Tempus AI Inc 公司

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Inc簡介

公司代碼TEM
公司名稱Tempus AI Inc
上市日期May 30, 2025
CEOLefkofsky (Eric P)
員工數量2400
證券類型Ordinary Share
年結日May 30
公司地址600 West Chicago Avenue
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60654
電話18335144187
網址https://investors.tempus.com/
公司代碼TEM
上市日期May 30, 2025
CEOLefkofsky (Eric P)

Tempus AI Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
1.25K
-1997.00%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 2月4日 週三
更新時間: 2月4日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
其他
62.65%
持股股東
持股股東
佔比
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
其他
62.65%
股東類型
持股股東
佔比
Investment Advisor
31.84%
Corporation
29.32%
Investment Advisor/Hedge Fund
11.69%
Individual Investor
7.45%
Research Firm
5.18%
Hedge Fund
4.27%
Holding Company
3.13%
Bank and Trust
0.95%
Venture Capital
0.91%
其他
5.27%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
742
96.30M
55.71%
+4.89M
2025Q3
619
75.72M
43.81%
-4.20M
2025Q2
501
136.83M
81.41%
-3.18M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Blue Media, LLC
18.14M
10.49%
-7.69M
-29.78%
Aug 08, 2025
BK TL21 LLC
15.22M
8.8%
--
--
Mar 18, 2025
Lefkofsky (Eric Paul)
11.70M
6.77%
-16.83K
-0.14%
Nov 25, 2025
The Vanguard Group, Inc.
9.42M
5.45%
+1.70M
+22.05%
Sep 30, 2025
Gray Media, LLC
9.27M
5.36%
-133.25K
-1.42%
Aug 08, 2025
Baillie Gifford & Co.
9.69M
5.61%
-2.40M
-19.86%
Sep 30, 2025
Red Sky LLC
8.06M
4.66%
-1.44M
-15.13%
Sep 30, 2025
ARK Investment Management LLC
7.18M
4.15%
-246.00K
-3.31%
Sep 30, 2025
SoftBank Group Corp
5.41M
3.13%
--
--
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ARK Genomic Revolution ETF
12.02%
ARK Innovation ETF
5.1%
Global X HealthTech ETF
4.22%
Franklin Genomic Advancements ETF
3.92%
Renaissance IPO ETF
3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
3.05%
AXS Green Alpha ETF
2.92%
ROBO Global Artificial Intelligence ETF
2.49%
First Trust Health Care Alphadex Fund
2.42%
Innovator IBD 50 Fund ETF
2.22%
查看更多
ARK Genomic Revolution ETF
佔比12.02%
ARK Innovation ETF
佔比5.1%
Global X HealthTech ETF
佔比4.22%
Franklin Genomic Advancements ETF
佔比3.92%
Renaissance IPO ETF
佔比3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
佔比3.05%
AXS Green Alpha ETF
佔比2.92%
ROBO Global Artificial Intelligence ETF
佔比2.49%
First Trust Health Care Alphadex Fund
佔比2.42%
Innovator IBD 50 Fund ETF
佔比2.22%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI